Irhythm Technologies Share Price (NASDAQ: IRTC)

$169.95

▲

-1.52

(-0.89%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Irhythm Technologies Stock chart to analyse performance

Irhythm Technologies stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$169.45
Today's High:$170.25
$169.95
0.29%
Downside
Day's Volatility :0.47%
Upside
0.18%
52 Weeks Low:$55.92
52 Weeks High:$172.59
$169.95
67.1%
Downside
52 Weeks Volatility :67.6%
Upside
1.53%

Irhythm Technologies Stock Returns

Period	Irhythm Technologies, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	21.02%	3.6%	0.0%
6 Months	56.01%	-7.7%	0.0%
1 Year	150.31%	-12.6%	0.0%
3 Years	13.28%	9.5%	-4.7%

Irhythm Technologies, Inc. Key Stats

Check Irhythm Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$171.47
Open	$169.45
Today's High	$170.25
Today's Low	$169.45
Market Capitalization	$5.5B
Today's Volume	$193.6K
52 Week High	$172.585
52 Week Low	$55.92
Revenue TTM	$657.2M
EBITDA	$-47.4M
Earnings Per Share (EPS)	$-2.91
Profit Margin	-14.06%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-91.14%

Stock Returns calculator for Irhythm Technologies Stock including INR - Dollar returns

The Irhythm Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Irhythm Technologies investment value today

Current value as on today

₹2,55,211

Returns

₹1,55,211

(+155.21%)

Returns from Irhythm Technologies Stock

₹1,49,926 (+149.93%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Irhythm Technologies Stock

-9%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Irhythm Technologies Stock from India on INDmoney has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Irhythm Technologies, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
10.07%
Sands Capital Management, LLC
9.07%
Artisan Partners Limited Partnership
8.53%
BlackRock Inc
8.41%
Capital Research Global Investors
4.69%
State Street Corp
2.86%

Analyst Recommendation on Irhythm Technologies Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Irhythm Technologies(by analysts ranked 0 to 5 stars)

Irhythm Technologies Share Price Target

What analysts predicted

Upside of 7.45%

Target:

$182.62

Current:

$169.95

Irhythm Technologies share price target is $182.62, a slight Upside of 7.45% compared to current price of $169.95 as per analysts' prediction.

Irhythm Technologies Stock Insights

Price Movement
In the last 1 month, IRTC stock has moved up by 21.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 158.67M → 186.68M (in $), with an average increase of 15.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -30.7M → -14.21M (in $), with an average increase of 115.9% per quarter
IRTC vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 145.2%

Irhythm Technologies, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$214.6M	↑ 45.66%
Net Income	$-54.6M	↑ 13.02%
Net Profit Margin	-25.43%	↑ 7.35%

	FY20	Y/Y Change
Revenue	$265.2M	↑ 23.59%
Net Income	$-43.8M	↓ 19.68%
Net Profit Margin	-16.53%	↑ 8.9%

	FY21	Y/Y Change
Revenue	$322.8M	↑ 21.74%
Net Income	$-101.4M	↑ 131.26%
Net Profit Margin	-31.4%	↓ 14.87%

	FY22	Y/Y Change
Revenue	$410.9M	↑ 27.29%
Net Income	$-116.2M	↑ 14.6%
Net Profit Margin	-28.27%	↑ 3.13%

	FY23	Y/Y Change
Revenue	$492.7M	↑ 19.9%
Net Income	$-123.4M	↑ 6.24%
Net Profit Margin	-25.05%	↑ 3.22%

	FY24	Y/Y Change
Revenue	$591.8M	↑ 20.13%
Net Income	$-113.3M	↓ 8.2%
Net Profit Margin	-19.14%	↑ 5.91%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$131.9M	↓ 0.44%
Net Income	$-45.7M	↑ 18.01%
Net Profit Margin	-34.61%	↓ 5.41%

	Q2 FY24	Q/Q Change
Revenue	$148.0M	↑ 12.22%
Net Income	$-20.1M	↓ 55.97%
Net Profit Margin	-13.58%	↑ 21.03%

	Q3 FY24	Q/Q Change
Revenue	$147.5M	↓ 0.34%
Net Income	$-46.2M	↑ 129.68%
Net Profit Margin	-31.3%	↓ 17.72%

	Q4 FY24	Q/Q Change
Revenue	$164.3M	↑ 11.38%
Net Income	$-1.3M	↓ 97.11%
Net Profit Margin	-0.81%	↑ 30.49%

	Q1 FY25	Q/Q Change
Revenue	$158.7M	↓ 3.44%
Net Income	$-30.7M	↑ 2203.08%
Net Profit Margin	-19.35%	↓ 18.54%

	Q2 FY25	Q/Q Change
Revenue	$186.7M	↑ 17.65%
Net Income	$-14.2M	↓ 53.69%
Net Profit Margin	-7.62%	↑ 11.73%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$162.1M	↑ 49.08%

	FY20	Y/Y Change
Profit	$194.9M	↑ 20.25%

	FY21	Y/Y Change
Profit	$213.6M	↑ 9.58%

	FY22	Y/Y Change
Profit	$281.6M	↑ 31.87%

	FY23	Y/Y Change
Profit	$331.8M	↑ 17.82%

	FY24	Y/Y Change
Profit	$407.5M	↑ 22.82%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$87.5M	↑ 0.1%

	Q2 FY24	Q/Q Change
Profit	$103.5M	↑ 18.23%

	Q3 FY24	Q/Q Change
Profit	$101.5M	↓ 1.93%

	Q4 FY24	Q/Q Change
Profit	$115.1M	↑ 13.39%

	Q1 FY25	Q/Q Change
Profit	$109.2M	↓ 5.09%

	Q2 FY25	Q/Q Change
Profit	$132.9M	↑ 21.65%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-21.9M	↓ 24.79%
Investing Cash Flow	$-89.3M	↓ 361.67%
Financing Cash Flow	$111.6M	↑ 1670.2%

	FY20	Y/Y Change
Operating Cash Flow	$-13.8M	↓ 37.07%
Investing Cash Flow	$-132.4M	↑ 48.3%
Financing Cash Flow	$214.3M	↑ 92.08%

	FY21	Y/Y Change
Operating Cash Flow	$-37.8M	↑ 174.39%
Investing Cash Flow	$105.3M	↓ 179.51%
Financing Cash Flow	$-28.6M	↓ 113.33%

	FY22	Y/Y Change
Operating Cash Flow	$-23.0M	↓ 39.05%
Investing Cash Flow	$-52.4M	↓ 149.81%
Financing Cash Flow	$26.7M	↓ 193.49%

	FY23	Y/Y Change
Operating Cash Flow	$-50.1M	↑ 117.72%
Investing Cash Flow	$-1.2M	↓ 97.69%
Financing Cash Flow	$8.8M	↓ 66.99%

	FY24	Y/Y Change
Operating Cash Flow	$3.4M	↓ 106.77%
Investing Cash Flow	$-123.0M	↑ 10072.29%
Financing Cash Flow	$511.4M	↑ 5697.97%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-52.0M	↑ 225.75%
Investing Cash Flow	$40.0M	↑ 2757.0%
Financing Cash Flow	$504.6M	↑ 14451.36%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$11.8M	↓ 122.76%
Investing Cash Flow	$14.5M	↓ 63.72%
Financing Cash Flow	$3.8M	↓ 99.25%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$24.3M	↑ 105.63%
Investing Cash Flow	$-55.3M	↓ 481.3%
Financing Cash Flow	$-35.0K	↓ 100.92%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$19.2M	↓ 21.01%
Investing Cash Flow	$-122.2M	↑ 120.77%
Financing Cash Flow	$3.0M	↓ 8634.29%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 141.03%
Investing Cash Flow	$-38.1M	↓ 68.78%
Financing Cash Flow	$1.7M	↓ 42.12%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$27.7M	↓ 450.51%
Investing Cash Flow	$-100.9M	↑ 164.6%
Financing Cash Flow	$7.1M	↑ 310.29%

Irhythm Technologies Technicals Summary

Sell

Neutral

Buy

Irhythm Technologies is currently in a neutral trading position according to technical analysis indicators.

Irhythm Technologies, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Irhythm Technologies, Inc.	21.42%	56.01%	150.31%	13.28%	-24.92%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Irhythm Technologies, Inc.	NA	NA	0.0	-1.5	-0.91	-0.04	NA	3.23
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Irhythm Technologies, Inc.	Buy	$5.5B	-24.92%	NA	-14.06%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

Irhythm Technologies Dividend announcements

Irhythm Technologies Earnings
Irhythm Technologies’s price-to-earnings ratio stands at None

About Irhythm Technologies, Inc.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Organization	Irhythm Technologies
Employees	2000
CEO	Mr. Quentin S. Blackford
Industry	Health Technology

Key Management of Irhythm Technologies, Inc.

Name	Title
Mr. Quentin S. Blackford	President, CEO & Director
Mr. Daniel G. Wilson	CFO & Principal Financial Officer
Dr. Minang P. Turakhia M.D., M.S.	Chief Medical & Scientific Officer and Executive VP of Advanced Technologies
Mr. Patrick Michael Murphy J.D.	Chief Business & Legal Officer
Mr. Chad M. Patterson	Chief Commercial and Product Officer
Mr. Mervin Smith	Executive Vice President of Business Operations
Mr. Marc Rosenbaum	Senior VP of Finance & Chief Accounting Officer
Mr. Brian Lawrence	Executive VP & CTO
Mr. Sean Clinton Freeman	Executive Vice President of Strategy & Corporate Development
Ms. Sumi Shrishrimal	Executive VP & Chief Risk Officer

Important FAQs about investing in IRTC Stock from India :

What is Irhythm Technologies share price today?

Irhythm Technologies share price today is $169.95 as on August 30, 2025 at 1:29 am IST at the close of the market. Irhythm Technologies share today touched a day high of $170.25 and a low of $169.45.

What is the 52 week high and 52 week low for Irhythm Technologies share?

Irhythm Technologies share touched a 52 week high of $172.59 and a 52 week low of $55.92. Irhythm Technologies stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $169.95, lower by 1.53% versus the 52 week high.

How to invest in Irhythm Technologies Stock (IRTC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Irhythm Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Irhythm Technologies Shares that will get you 0.0088 shares as per Irhythm Technologies share price of $169.95 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Irhythm Technologies Stock (IRTC) from India?

Indian investors can start investing in Irhythm Technologies (IRTC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Irhythm Technologies stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Irhythm Technologies share’s latest price of $169.95 as on August 30, 2025 at 1:29 am IST, you will get 0.0588 shares of Irhythm Technologies. Learn more about fractional shares .

What are the returns that Irhythm Technologies has given to Indian investors in the last 5 years?

Irhythm Technologies stock has given -24.92% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?